Literature DB >> 29507028

Stroke thrombolysis complicated by ST elevation myocardial infarction (STEMI).

Mark Flower1, James Harvey1, Jonathan Hunter1.   

Abstract

An 84-year-old male Jehovah's Witness presented to the emergency department 1 hour after onset of left facial droop and left upper limb weakness. Thrombolytic stroke treatment was commenced as per local thrombolytic protocol with intravenous recombinant tissue plasminogen activator (rtPA) at 2 hours and 25 min following onset of symptoms. Almost immediately after rtPA infusion the patient reported chest pain and had ECG changes consistent with a diagnosis of anterior ST elevation myocardial infarction. At angiogram, a graft study showed severe native coronary artery disease. The left internal mammary artery graft was patent to the left anterior descending artery (LAD); however, the apical LAD was occluded, with the appearance suggestive of embolic occlusion. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  ischaemic heart disease; safety; stroke; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2018        PMID: 29507028      PMCID: PMC5847940          DOI: 10.1136/bcr-2017-223580

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study.

Authors:  Eric L Wallace; Susan S Smyth
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

2.  Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger.

Authors:  Adatia Sweta; Sanghani Sejal; Sanzgiri Prakash; Chauhan Vinay; Hastak Shirish
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

3.  Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.

Authors:  Daniel J Miller; Jennifer R Simpson; Brian Silver
Journal:  Neurohospitalist       Date:  2011-07

Review 4.  Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.

Authors:  L Derex; N Nighoghossian
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01-25       Impact factor: 10.154

5.  A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.

Authors:  Heesoo Joo; Guijing Wang; Mary G George
Journal:  Stroke Vasc Neurol       Date:  2017-04-28

6.  Myocardial infarction following t-PA for acute stroke.

Authors:  M Mehdiratta; C Murphy; A Al-Harthi; P A Teal
Journal:  Can J Neurol Sci       Date:  2007-11       Impact factor: 2.104

Review 7.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.

Authors:  Jonathan Emberson; Kennedy R Lees; Patrick Lyden; Lisa Blackwell; Gregory Albers; Erich Bluhmki; Thomas Brott; Geoff Cohen; Stephen Davis; Geoffrey Donnan; James Grotta; George Howard; Markku Kaste; Masatoshi Koga; Ruediger von Kummer; Maarten Lansberg; Richard I Lindley; Gordon Murray; Jean Marc Olivot; Mark Parsons; Barbara Tilley; Danilo Toni; Kazunori Toyoda; Nils Wahlgren; Joanna Wardlaw; William Whiteley; Gregory J del Zoppo; Colin Baigent; Peter Sandercock; Werner Hacke
Journal:  Lancet       Date:  2014-08-05       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.